-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Metagenomi, Lowers Price Target to $16

Benzinga·05/14/2025 14:37:54
Listen to the news
Wells Fargo analyst Yanan Zhu maintains Metagenomi (NASDAQ:MGX) with a Overweight and lowers the price target from $20 to $16.